HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

DoshaCare: Company grows its Ayurveda-based product portfolio with introduction of SPF 28 sunscreen ($29 for 50 ml) to its Sakala range, reminding consumers that "sun protection is a year-round proposition." According to recent release, product contains micronized zinc oxide for broad-spectrum ultraviolet protection; neem, macadamia nut oil and aloe vera to prevent damage due to direct sun exposure; and micro-sponges to absorb oil throughout the day. The sunscreen joins lineup comprising Exfoliant, "pore-purifying" Ama Release Tonic, Hydrating Eye and Neck Balm and Environmental Shield. Sakala blends enjoy attributes from DoshaCare's three customized lines - Vata, for dehydrated/dry skin, Pitta, for normal/sensitive skin, and Kapha, for oily/congested skin - in "euphoric harmony," targeted to all skin types. Torrance, Calif., manufacturer says 98% of ingredients used in its products are botanical-derived, and "most are organic." Ancient Indian healing system of Ayurveda serves as the basis for a popular subsection of the natural/organic personal-care market (1"The Rose Sheet" June 9, 2008). Estee Lauder's investment in Ayurvedic brand Forest Essentials broadened its presence in India (2"The Rose Sheet" Aug. 4, 2008)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel